重症肺炎继发急性呼吸窘迫综合征的精准个体化评估
重症肺炎是ARDS最常见病因,精准个体化评估是提高救治效果的前提。呼吸生理指标、胸部影像学和炎症免疫亚型评估可用于指导个体化通气、撤机和精准治疗,人工智能整合多模态数据是未来方向。
要点
- 驱动压、机械功率、呼吸驱动和吸气努力与ARDS病死率显著相关。
- 胸部CT、超声和电阻抗断层扫描可评估形态学改变和区域肺通气。
- 炎症免疫状态与生物学亚型评估为糖皮质激素等精准治疗提供依据。
核心结论
- 重症肺炎是ARDS最常见病因,精准个体化评估是提高救治效果的前提。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 近期前瞻性队列研究证实驱动压、机械功率、呼吸驱动和吸气努力等生理指标与ARDS患者病死率显著相关。
- 胸部影像学技术能准确评估ARDS肺组织形态学改变并动态呈现区域性肺通气功能。
- 炎症免疫状态与生物学亚型评估有助于揭示病理生理机制并为糖皮质激素等精准治疗提供依据。
临床怎么用
- 床旁呼吸生理指标可用于指导个体化通气参数设置和撤机评估。
- 胸部影像学技术可用于精准诊断、个体化通气设置和撤机评估。
- 炎症免疫状态与生物学亚型评估可为糖皮质激素等精准治疗提供依据。
- 人工智能可整合多模态数据构建预测模型,识别疾病进展轨迹并推进临床决策支持系统实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe pneumonia is the most common cause of acute respiratory distress syndrome (ARDS), and precise and individualized assessment is a prerequisite for improving therapeutic outcomes. Of all bedside assessment tools, respiratory physiological indicators are the most readily available and widely adopted, covering key metrics including gas exchange, respiratory mechanics, respiratory drive, and inspiratory effort. Recent prospective cohort investigations have validated that physiological metrics, including driving pressure, mechanical power, respiratory drive, and inspiratory effort, correlate strongly with mortality among patients with ARDS. Furthermore, thoracic imaging technologies (such as chest CT, ultrasound, and electrical impedance tomography) can accurately evaluate morphological alterations in ARDS lung tissue and dynamically visualize regional lung ventilation function. These tools have demonstrated considerable clinical utility for facilitating precise diagnosis, tailoring individualized ventilation settings, and assessing weaning readiness. Additionally, evaluating inflammatory immune status and biological subphenotypes not only helps elucidate the core pathophysiological mechanisms underlying ARDS secondary to severe pneumonia, but also provides a rationale for precision therapies using medications such as glucocorticoids. Bedside assessment indicators are growing in variety and availability. Artificial intelligence can efficiently integrate and analyze these large-scale multimodal datasets to construct predictive models. These models can track disease progression trajectories, optimize ARDS management, and advance the translation of Clinical Decision Support Systems into clinical practice. This approach represents a vital direction for future research. 重症肺炎是急性呼吸窘迫综合征(ARDS)最常见的病因,精准个体化评估是提高救治效果的前提。在床旁评估方法中,呼吸生理指标最易获得且最为常用,主要包括气体交换、呼吸力学和呼吸驱动/吸气努力等参数。近期多项前瞻性队列研究证实,驱动压、机械功率、呼吸驱动和吸气努力等生理指标均与ARDS患者病死率显著相关。另外,胸部影像学技术(如胸部CT、超声、电阻抗断层扫描等)能够准确地评估ARDS肺组织的形态学改变,并能动态呈现区域性肺通气功能,在指导精准诊断、个体化通气参数设置和撤机评估等方面展现了重要价值。此外,炎症免疫状态与生物学亚型评估不仅有助于揭示重症肺炎所致ARDS的关键病理生理学机制,也为糖皮质激素等药物的精准治疗提供了依据。随着床旁可及的评估指标日益丰富,如何借助人工智能技术高效整合与分析这些海量多模态数据,构建预测模型识别疾病进展轨迹,提升ARDS诊疗水平以及推进临床决策支持系统的实施,是未来重要的研究方向。.
引用
- Zhan QY, Xia JG, He HY, et al. [Acute respiratory distress syndrome secondary to severe pneumonia: how to perform precise and individualized assessment]. Zhonghua Jie He He Hu Xi Za Zhi. 2026. PMID: 42811561. doi:10.3760/cma.j.cn112147-20260618-00369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。